In Situ Ophthalmic Gel of Ciprofloxacin Hydrochloride for Once a Day Sustained Delivery

REFERENCES

• Aggarwal D., Kaur I. P. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int. J. Pharm. 2005; 290: 155–159
   PubMed Web of Science ®Google Scholar
• Balasubramaniam J., Kant S., Pandit J. K. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 2003; 53: 251–261
   PubMedGoogle Scholar
• Balasubramaniam J., Pandit J. K. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv. 2003; 10: 185–191
   PubMed Web of Science ®Google Scholar
• Basak S. C., Jayakumar R. B. M., Lucas M. K. P. Formulation and release behaviour of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian J. Pharm. Sci. 2006; 68: 594–598
   Google Scholar
• Bottari F., Dicolo G., Nannipieri E., Saettone M. F., Serafini M. F. Influence of drug concentration on in vitro release of salicylic acid from ointment bases. J. Pharm. Sci. 1974; 63: 1779–1783
   PubMed Web of Science ®Google Scholar
• Cho K. Y., Chung T. W., Kim B. C., Kim M. K., Lee J. H., Wee W. R., et al. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int. J. Pharm. 2003; 260: 83–91
   PubMed Web of Science ®Google Scholar
• Cho K. Y., Chung T. W., Song H. H., Choi Y. J., Kwon J. W., Kim M. K., et al. Release of ciprofloxacin from chondroitin 6-sulfate-graft-poloxamer hydrogel in vitro for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 2005; 31: 455–463
   PubMed Web of Science ®Google Scholar
• Desai S. D., Blanchard J. Ocular drug formulation and delivery. Encylopedia of pharmaceutical technology, J. Swarbrick, J. C. Boylan. Marcel Dekker, Inc, New York 1995; 11: 43–75
   Google Scholar
• Dotegham M. M. V. Formulation of ophthalmic solutions and suspensions. Problems and advantages. Biopharmaceutics of ocular drug delivery, P. Edman. CRC Press, Boca Raton, FL 1993; 27–42
   Google Scholar
• El-Kamel A. H. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm. 2002; 241: 47–55
   PubMed Web of Science ®Google Scholar
• Gurny R., Boye T., Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J. Control. Release 1985; 2: 353–361
   Google Scholar
• Hsiue G. H., Chang R. W., Wang C. H., Lee S. H. Development of in situ thermosensitive drug vehicles for glaucoma therapy. Biomaterials 2003; 24: 2423–2430
   PubMed Web of Science ®Google Scholar
• Kamath R., Singh U. V., Udupa N. Evaluation of ciprofloxacin hydrochloride ocular preparations. Int. J. Pharm. 1993; 55: 148–150
   Google Scholar
• Korsmeyer M., Gurny R., Doelker E., Buri P., Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
   Web of Science ®Google Scholar
• Liu Z., Li J., Nie S., Liu H., Ding P., Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int. J. Pharm. 2006; 315: 12–17
   PubMed Web of Science ®Google Scholar
• Mandell G. L., Sande M. A. Antimicrobial agents: Sulfonamides, trimethoprim, sulfamethaxazole, quinolones and agents for urinary tract infections. The pharmacological basis of therapeutics9th, A. G. Gilman. McGraw Hill, New York 1996; 1057–1072
   Google Scholar
• Middleton D. L., Leung S. S., Robinson J. R. Ocular biodhesive delivery systems. Bioadhesive drug delivery systems, V. Lenaerts, R. Gurny. CRC Press, Boca Raton, FL 1990; 179–202
   Google Scholar
• Mockel J., Lippold B. Zero order drug release from hydrocolloid matrices. Pharm. Res. 1993; 10: 1066–1070
   PubMed Web of Science ®Google Scholar
• Olejnik O. Conventional systems in ophthalmic drug delivery. Ophthalmic drug delivery systems, A. K. Mitra. Marcel Dekker, New York 1993; 179–193
   Google Scholar
• Organization for Economic Co-operation and Development. Guidelines for testing the chemicals: Guideline No. 405. ‘Acute eye irritation/corrosion’ OECD Publication Office, Paris 1987
   Google Scholar
• Qi H., Chen W., Huang C., Li L., Chen C., Li W., et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int. J. Pharm. 2007; 337: 178–187
   PubMed Web of Science ®Google Scholar
• Reddy K. R., Mutalik S., Reddy S. Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation. AAPS Pharm. Sci. Tech. 2003; 4: e61
   PubMedGoogle Scholar
• Reynolds J. E. F., Martindale W. The extra pharmacopoeia33rd. The Pharmaceutical Press, London 2002
   Google Scholar
• Sechoy O., Tissie G., Sebastian C., Maurin F., Driot J. Y. A new long acting ophthalmic formulation of Carteolol containing alginic acid. Int. J. Pharm. 2000; 207: 109–116
   PubMed Web of Science ®Google Scholar
• Spancake C. W., Mitra A. K., Kildsig D. O. Kinetics of aspirin hydrolysis in aqueous solutions and gels of poloxamines (Tetronic 1508). Influence of microenvironment. Int. J. Pharm. 1991; 75: 231–239
   Web of Science ®Google Scholar
• Sultana Y., Aqil M., Ali A., Zafar S. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm. Dev. Technol. 2006; 11: 313–319
   PubMed Web of Science ®Google Scholar
• Tsai A. C., Tseng M. C., Chang S. W., Hu F. R. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J. Formos. Med. Assoc. 1995; 94: 760–764
   PubMed Web of Science ®Google Scholar
• Wu C., Qi H., Chen W., Huang C., Su C., Li W., et al. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi 2007; 127: 183–191
   PubMed Web of Science ®Google Scholar